PSMA PET/CT Identifies Intrapatient Variation in Salivary Gland Toxicity From Iodine-131 Therapy.
CONCLUSIONS: 131I-therapy can induce salivary gland toxicity with high inter- but also high intrapatient variation among separate gland locations, which can be assessed with PSMA PET/CT. This new technique offers potential to guide further development and evaluation of protective measures in patients receiving 131I-therapy.
PMID: 32619138 [PubMed - as supplied by publisher]
Source: Molecular Imaging - Category: Radiology Tags: Mol Imaging Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | CT Scan | Iodine | PET Scan | Radiology | Thyroid | Thyroid Cancer | Toxicology | Xerostomia